BC
ASPX

Birchview Capital’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Birchview Capital’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,000
Closed -$902K – 42
2015
Q1 		$902K Sell
9,000
-16,500
-65% -$1.1M 0.47% 19
2014
Q4 		$1.34M Buy
+25,500
New +$749K 0.78% 11

Birchview Capital's ASPX Position: Q2 2015 in Review

Birchview Capital sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 9,000 shares — an estimated $902K sold.

Birchview Capital first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $1.34M in Q4 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Birchview Capital reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Birchview Capital sold 9,000 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $902K.
  • Birchview Capital first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Birchview Capital's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.34M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Birchview Capital's 13F filing for Q2 2015, filed 13 Aug 2015.